TY  - JOUR 
AU  - Izquierdo, María Jesús .
AU  - Cavia Saiz, Mónica
AU  - Muñiz Rodríguez, Pilar
AU  - Francisco, Angel LM de .
AU  - Arias, Manuel .
AU  - Santos, Javier .
AU  - Abaigar, Pedro
PY  - 2012
SN  - 1471-2369
UR  - http://hdl.handle.net/10259.4/2515
AB  - Background: Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert
an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and
independently of...
AB  - Background: Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of...
LA  - eng
PB  - BioMed Central
KW  - Oxidative Stress
KW  - Immunomodulation
KW  - Receptors
KW  - Calcitrio
KW  - Paricalcitol
KW  - 19-nor-1alpha
KW  - 25-dihydroxyvitamin D2
KW  - Bioquímica
KW  - Biochemistry
KW  - Biología molecular
KW  - Molecular biology
TI  - Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
ER  -